Get the Stockscreener App
6.61
1.49%
-0.10
After Hours:
6.79
0.18
+2.72%
Champions Oncology Inc stock is traded at $6.61, with a volume of 3,556.
It is down -1.49% in the last 24 hours and up +9.44% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$6.71
Open:
$6.685
24h Volume:
3,556
Relative Volume:
0.24
Market Cap:
$91.79M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-9.3099
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
+0.90%
1M Performance:
+9.44%
6M Performance:
-13.93%
1Y Performance:
-30.20%
1-Day Range:
$6.58
$6.7899
1-Week Range:
$6.55
$6.93
52-Week Range:
$5.592
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.61 | 93.18M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
(CSBR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Holdings Limited Price Holds Above Key Fib LevelSmall Cap Stock Opportunities & Big Profit Small Investment - bollywoodhelpline.com
Revenue per share of Champions Oncology, Inc. – MUN:2I3 - TradingView — Track All Markets
How Champions Oncology Inc stock benefits from tech adoptionJuly 2025 Snapshot & Safe Swing Trade Setups - moha.gov.vn
Can Sula Vineyards Limited (SULA) Maintain Its ValuationCandlestick Trading Patterns & Ride the Wave of Market-Beating Growth - bollywoodhelpline.com
Link Pharma Chem Limited (524748) Announces Strategic ShiftPrice Channel Trading & Learn the Basics of Investing in 5 Days - bollywoodhelpline.com
Swelect Energy Systems Ltd(Salutations to Lord Sun)Volatility Adjusted Trading & Superior Capital Appreciation - bollywoodhelpline.com
Will Breakout in Ceejay Finance Limited Sustain Through Next WeekTechnical Analysis Insights & Rapid Portfolio Trading Growth - bollywoodhelpline.com
Learn from historical chart patterns and price movementsStock Liquidity Analysis & Learn to Think Like a Long-Term Investor - bollywoodhelpline.com
Analysts Spot Bullish Divergence in CarTrade Tech LimitedEarnings Beat Highlights & Small Budget Capital Gains - bollywoodhelpline.com
FIIs were net sellers but DIIs absorbed selling pressure.Earnings Surprise Analysis & Free Dynamic Profit Opportunities - bollywoodhelpline.com
Vardhman Polytex Limited Breaks Below Key Support LevelDividend Cut Warnings & Free Strong Return On Assets - bollywoodhelpline.com
Watch for bullish price action in retest zoneBear Market Strategies & Small Investment Portfolio Tips - bollywoodhelpline.com
Behavioral Patterns of CSBR and Institutional Flows - Stock Traders Daily
Macro Trends and Their Impact on Sal Automotive Limited (539353)Analyst Upgrades & High Profit Trading Signals - bollywoodhelpline.com
Wires Limited With Promising ResultsGap Up/Gap Down Analysis & Rapid Wealth Accumulation - Bollywood Helpline
Machine Learning Models Forecast Sanathan Textiles Limited UptickPortfolio Allocation Tips & Low Risk Investment Plans - Bollywood Helpline
Iron Ores Limited Shows Support at Fibonacci LevelDividend Stability Analysis & Individual Stock Tracking Service - bollywoodhelpline.com
Will Alliant Energy Corporation stock benefit from sector rotationMorning Star Patterns & Low Cost Capital Growth - bollywoodhelpline.com
Screener Results Flag Hisar Metal Industries Limited as OversoldTrading Volume Surges & Free Superior Stock Performance - Bollywood Helpline
IV shows the market’s expectation of future volatility.Fibonacci Extensions & Low Cost Capital Growth - Bollywood Helpline
Candlestick Reversal Detected on Kranti Industries Limited’s ChartAnalyst Upgrades & Fast Profit Strategies - bollywoodhelpline.com
Inside the World’s Most Characterized Pretreated Tumor Collection: How Integrated Model Systems Are Powering Predictive and Ethical Oncology Research - Onco'Zine
Tangible book value per share of Champions Oncology, Inc. – MUN:2I3 - TradingView — Track All Markets
Suven Life Sciences Limited Volume Confirms Breakout — Analysts BullishEconomic Data Impact & Free Explosive Trading Growth - Bollywood Helpline
Is Champions Oncology Inc. stock a defensive play in 20252025 Retail Activity & Step-by-Step Swing Trade Plans - ulpravda.ru
Is ARHS stock attractive after correctionJuly 2025 Earnings & AI Optimized Trading Strategy Guides - Улправда
JMG Corporation Limited Flashes Rebound Signal in Oversold ConditionFibonacci Retracement Levels & Breakout Portfolio Performance - Bollywood Helpline
Can Champions Oncology Inc. stock sustain market leadershipPortfolio Gains Report & Smart Investment Allocation Insights - Улправда
Champions Oncology Earnings Notes - Trefis
Can Champions Oncology Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Weekly High Return Stock Forecasts - Улправда
Aug Decliners: Can Champions Oncology Inc. stock outperform in 2025 bull market2025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда
Will Champions Oncology Inc. stock keep outperforming rivalsQuarterly Portfolio Report & Accurate Buy Signal Notifications - DonanımHaber
Can Champions Oncology Inc. (2I3) stock retain market dominanceJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Улправда
Aug Momentum: Can Champions Oncology Inc. stock outperform in 2025 bull marketJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - Улправда
ETFs Investing in Champions Oncology, Inc. Stocks - TradingView — Track All Markets
Champions Oncology (CSBR) Q2 EPS Profit Supports Bullish High‑Quality Earnings Narrative - Sahm
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2026 Earnings Call Transcript - Insider Monkey
Champions Oncology Inc Stock Analysis and ForecastSwing Trading Watchlist & Rapid Capital Portfolio - earlytimes.in
Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Champions Oncology earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Champions Oncology signals expanding radiolabeling and data platform as margin improves to 52% - MSN
CSBR: Revenue up 11% and gross margin at 52%, with strong growth in radiolabeling and data platforms - TradingView — Track All Markets
Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips - GuruFocus
Earnings call transcript: Champions Oncology Q2 2025 sees strong revenue growth - Investing.com
Champions Oncology Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView — Track All Markets
CSBR: Quarterly oncology revenue rose 11.5% year-over-year, but higher costs led to a six-month net loss - TradingView — Track All Markets
Champions Oncology, Inc. (NASDAQ: CSBR) posts Q2 growth with rising R&D spend - Stock Titan
Champions Oncology Reports Record Quarterly Service Revenue - TradingView — Track All Markets
CSBR: Q2 revenue up 11% to $15M, oncology margin hits 52%, outlook remains positive - TradingView — Track All Markets
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):